Skip to content
WorldBrand.AI

Qilu Pharmaceutical controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile2 entries

  1. 2021

    Pfizer plaintiffs sue Qilu over Ibrance patent

    Lawsuit filed

    Pfizer and co-plaintiffs filed suit against Qilu in the District of Delaware, seeking a declaration of patent infringement and an order barring further infringement. The complaint concerns the patent for Ibrance; the infringement claims are allegations in the lawsuit.

    Source excerpt

    • The plaintiffs are seeking a declaratory judgement of patent infringement and an order enjoining Qilu from further infringement. The case concerns the patent for Ibrance, used to treat breast cancer.
    • Pfizer, Inc. (Pfizer), Warner-Lambert Company LLC, and PF Prison IMB B.V. filed suit on Tuesday against Qilu Pharmaceutical Co., LTD, and Qilu Pharma, Inc. (Qilu) in the District of Delaware.
    Source

  2. 2019

    Accident at subsidiary Tianhe Huishi kills 10

    In April 2019, an accident occurred during maintenance work at Qilu Tianhe Huishi, a subsidiary of Qilu Pharmaceutical, causing 10 deaths, and relevant authorities launched an investigation. This entry records a subsidiary's production safety accident and does not equate the investigation progress in initial reports with a final criminal liability conclusion.

    Source